Roadmap for Clinicians
Clear milestones. Real-world testing. From early access to powerful features—here’s what to expect, and when.
Access the current beta of Thalivia (Solo plan). Test in real conditions, provide feedback, and help shape the product before V1 launch.
Launch of the full Solo version with country-specific adaptations for initial target markets. Structured prescription, charge programming, patient records, CE-compliant.
Expert-led webinars with Dr. Denis Dupoiron and Key Opinion Leaders. Live case discussions, clinical demos, and Q&A sessions.
Launch of structured eLearning modules and multi-user Team accounts with collaborative patient sharing and role management.
Full hospital-grade features: SSO, FHIR/HL7 integration, pharmacy workflows, institutional compliance and support.
Built With and For Clinicians
Each milestone in Thalivia’s roadmap reflects direct input from medical users. Whether you’re prescribing today or planning for team collaboration, here’s what’s ahead:
At a Glance
- Early Access (Now – Dec 2025) – Request beta access to Solo plan and help shape V1
- V1 Launch (Feb 2026) – Full Solo release with country-specific adaptations
- Webinars (Q1 2026) – Expert-led sessions with Dr. Dupoiron and KOLs
- eLearning & Team (Dec 2026) – Continuing education and collaborative workflows
- Enterprise (Q3 2026) – Full hospital-grade features with SSO and FHIR integration
You can help shape the future of intrathecal pain therapy—starting today.
Explore what's coming to your clinical practice with Thalivia. Your feedback helps us build the future of intrathecal care.
